New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
08:04 EDTSTJSt. Jude says RESPECT data show device group patients had fewer, smaller strokes
St. Jude Medical announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Associationís International Stroke Conference 2013 in Honolulu. The RESPECT trial evaluated whether closing an opening in the heart, called a patent foramen ovale or PFO, with the AMPLATZER PFO Occluder lowered the patientís risk of having another stroke. The purpose of analyzing these additional data from the RESPECT trial was to determine if patients in the device and medical therapy group suffered different types of recurrent strokes, and to identify the potential origin of the strokes. The results confirm that patients with a device in place were less likely to suffer another stroke and patients in the medical group experienced larger strokes. PFO closure with the AMPLATZER PFO Occluder demonstrates clinical evidence of risk reduction and is an important option for the prevention of recurrent stroke in carefully selected patients over conventional medical management alone.
News For STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 14, 2015
09:03 EDTSTJSt. Jude Medical sees Q4 adjusted EPS within $1.02-$1.04 guidance range
Subscribe for More Information
09:02 EDTSTJSt. Jude Medical sees Q4 net sales approximately $1.439B, consensus $1.44B
Subscribe for More Information
09:01 EDTSTJSt. Jude Medical authorizes $500M share repurchase program
The company announced that its board of directors has authorized the repurchase of up to $500M of St. Jude Medical common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Any shares acquired in the $500M repurchase program will be available for general corporate purposes, including offsetting dilution associated with stock option and other equity-based employee benefit plans. The company had approximately 287 million shares of common stock outstanding as of Jan. 13, 2015.
January 12, 2015
07:17 EDTSTJJPMorgan to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use